BMY Bristol Myers Squibb Co
- Stocks
- Healthcare
- NYSE: BMY
Price (delayed)
$48.44
Market cap
$98.6B
P/E Ratio
19.45
Dividend/share
$2.46
EPS
$2.49
Enterprise value
$135.18B
Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease,
Highlights
BMY's debt is down by 6% year-on-year
The company's revenue rose by 2.6% YoY
Bristol Myers Squibb's EPS has surged by 177% YoY but it has decreased by 7% QoQ
The net income has surged by 177% year-on-year but it has declined by 7% since the previous quarter
The gross margin has decreased by 7% YoY
Bristol Myers Squibb's gross profit has decreased by 4.4% YoY
Key stats
What are the main financial stats of BMY
Market
Valuations
Earnings
Shares outstanding
2.04B
Market cap
$98.6B
Enterprise value
$135.18B
Price to earnings (P/E)
19.45
Price to book (P/B)
5.65
Price to sales (P/S)
2.07
EV/EBIT
20.55
EV/EBITDA
10.34
EV/Sales
2.83
Revenue
$47.7B
Gross profit
$33.53B
Operating income
$6.59B
Net income
$5.05B
EBIT
$6.58B
EBITDA
$13.07B
Free cash flow
$14.58B
Per share
Balance sheet
Liquidity
EPS
$2.49
EPS diluted
$2.48
Free cash flow per share
$7.16
Book value per share
$8.57
Revenue per share
$23.44
TBVPS
$25.32
Total assets
$94.68B
Total liabilities
$77.19B
Debt
$49.19B
Equity
$17.44B
Working capital
$5.69B
Debt to equity
2.82
Current ratio
1.21
Quick ratio
0.91
Net debt/EBITDA
2.8
Margins
Efficiency
Dividend
EBITDA margin
27.4%
Gross margin
70.3%
Net margin
10.6%
Operating margin
13.8%
Return on assets
5.4%
Return on equity
29.6%
Return on invested capital
10.5%
Return on capital employed
9.8%
Return on sales
13.8%
Dividend yield
5.08%
DPS
$2.46
Payout ratio
98.8%
BMY stock price
How has the Bristol Myers Squibb stock price performed over time
Intraday
1.32%
1 week
5.42%
1 month
4.33%
1 year
-1.36%
YTD
-14.36%
QTD
4.64%
Financial performance
How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$47.7B
Gross profit
$33.53B
Operating income
$6.59B
Net income
$5.05B
Gross margin
70.3%
Net margin
10.6%
The operating margin has surged by 200% year-on-year and by 8% since the previous quarter
The net income has surged by 177% year-on-year but it has declined by 7% since the previous quarter
BMY's net margin has soared by 175% year-on-year but it is down by 7% since the previous quarter
The operating income rose by 8% since the previous quarter
Price vs fundamentals
How does BMY's price correlate with its fundamentals
Growth
What is Bristol Myers Squibb's growth rate over time
Valuation
What is Bristol Myers Squibb stock price valuation
P/E
19.45
P/B
5.65
P/S
2.07
EV/EBIT
20.55
EV/EBITDA
10.34
EV/Sales
2.83
Bristol Myers Squibb's EPS has surged by 177% YoY but it has decreased by 7% QoQ
BMY's P/B is 18% above its 5-year quarterly average of 4.8 but 12% below its last 4 quarters average of 6.4
Bristol Myers Squibb's equity has increased by 2.5% YoY
The price to sales (P/S) is 29% less than the 5-year quarterly average of 2.9 and 10% less than the last 4 quarters average of 2.3
The company's revenue rose by 2.6% YoY
Efficiency
How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's return on sales has surged by 200% YoY and by 8% QoQ
BMY's return on invested capital has surged by 195% year-on-year and by 11% since the previous quarter
Bristol Myers Squibb's ROA has soared by 178% YoY but it has decreased by 7% from the previous quarter
The ROE has contracted by 7% from the previous quarter
Dividends
What is BMY's dividend history
DPS
$2.46
Dividend yield
5.08%
Payout ratio
98.8%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Bristol Myers Squibb financials performed over time
BMY's total assets is 23% greater than its total liabilities
The quick ratio has increased by 17% YoY but it has decreased by 3.2% QoQ
Bristol Myers Squibb's current ratio has decreased by 5% from the previous quarter but it has increased by 4.3% YoY
BMY's debt is 182% greater than its equity
The company's debt to equity fell by 8% YoY
BMY's debt is down by 6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.